Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Increased alternative lengthening of telomere phenotypes of telomerase-negative immortal cells upon trichostatin--a treatment.

Jung AR, Yoo JE, Shim YH, Choi YN, Jeung HC, Chung HC, Rha SY, Oh BK.

Anticancer Res. 2013 Mar;33(3):821-9.

PMID:
23482750
2.

Reversible conversion of immortal human cells from telomerase-positive to telomerase-negative cells.

Kumakura S, Tsutsui TW, Yagisawa J, Barrett JC, Tsutsui T.

Cancer Res. 2005 Apr 1;65(7):2778-86.

3.

Telomere elongation facilitated by trichostatin a in cloned embryos and pigs by somatic cell nuclear transfer.

Kong Q, Ji G, Xie B, Li J, Mao J, Wang J, Liu S, Liu L, Liu Z.

Stem Cell Rev. 2014 Jun;10(3):399-407. doi: 10.1007/s12015-014-9499-y.

PMID:
24510582
5.

Alternative lengthening of telomeres in hTERT-inhibited laryngeal cancer cells.

Chen W, Xiao BK, Liu JP, Chen SM, Tao ZZ.

Cancer Sci. 2010 Aug;101(8):1769-76. doi: 10.1111/j.1349-7006.2010.01611.x. Epub 2010 May 8.

7.

A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT.

Cerone MA, Autexier C, Londoño-Vallejo JA, Bacchetti S.

Oncogene. 2005 Nov 24;24(53):7893-901.

PMID:
16116482
8.

Alternative lengthening of telomeres (ALT) and chromatin: is there a connection?

Nittis T, Guittat L, Stewart SA.

Biochimie. 2008 Jan;90(1):5-12. Epub 2007 Sep 2. Review.

PMID:
17935854
9.

Alternative lengthening of telomeres is characterized by high rates of telomeric exchange.

Londoño-Vallejo JA, Der-Sarkissian H, Cazes L, Bacchetti S, Reddel RR.

Cancer Res. 2004 Apr 1;64(7):2324-7.

10.

Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids.

Perrem K, Bryan TM, Englezou A, Hackl T, Moy EL, Reddel RR.

Oncogene. 1999 Jun 3;18(22):3383-90.

11.

Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway.

Grobelny JV, Kulp-McEliece M, Broccoli D.

Hum Mol Genet. 2001 Sep 1;10(18):1953-61.

PMID:
11555632
12.

Inter-telomeric recombination is present in telomerase-positive human cells.

Dlaska M, Schöffski P, Bechter OE.

Cell Cycle. 2013 Jul 1;12(13):2084-99. doi: 10.4161/cc.25136. Epub 2013 Jun 6.

13.

Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.

Brachner A, Sasgary S, Pirker C, Rodgarkia C, Mikula M, Mikulits W, Bergmeister H, Setinek U, Wieser M, Chin SF, Caldas C, Micksche M, Cerni C, Berger W.

Cancer Res. 2006 Apr 1;66(7):3584-92.

14.

Telomere maintenance in Wilms tumors: first evidence for the presence of alternative lengthening of telomeres mechanism.

Venturini L, Daidone MG, Motta R, Collini P, Spreafico F, Terenziani M, Piva L, Radice P, Perotti D, Zaffaroni N.

Genes Chromosomes Cancer. 2011 Oct;50(10):823-9. doi: 10.1002/gcc.20903. Epub 2011 Jul 18.

PMID:
21769957
15.

Telomerase suppresses formation of ALT-associated single-stranded telomeric C-circles.

Plantinga MJ, Pascarelli KM, Merkel AS, Lazar AJ, von Mehren M, Lev D, Broccoli D.

Mol Cancer Res. 2013 Jun;11(6):557-67. doi: 10.1158/1541-7786.MCR-13-0013. Epub 2013 Mar 15.

16.

Telomere maintenance by telomerase and by recombination can coexist in human cells.

Cerone MA, Londono-Vallejo JA, Bacchetti S.

Hum Mol Genet. 2001 Sep 1;10(18):1945-52.

PMID:
11555631
17.

The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells.

Hou M, Wang X, Popov N, Zhang A, Zhao X, Zhou R, Zetterberg A, Björkholm M, Henriksson M, Gruber A, Xu D.

Exp Cell Res. 2002 Mar 10;274(1):25-34.

PMID:
11855854
18.

Topoisomerase II inhibition suppresses the proliferation of telomerase-negative cancers.

Hsieh MH, Tsai CH, Lin CC, Li TK, Hung TW, Chang LT, Hsin LW, Teng SC.

Cell Mol Life Sci. 2015 May;72(9):1825-37. doi: 10.1007/s00018-014-1783-0. Epub 2014 Nov 28.

PMID:
25430478
19.

Alternative Lengthening of Telomeres is characterized by reduced compaction of telomeric chromatin.

Episkopou H, Draskovic I, Van Beneden A, Tilman G, Mattiussi M, Gobin M, Arnoult N, Londoño-Vallejo A, Decottignies A.

Nucleic Acids Res. 2014 Apr;42(7):4391-405. doi: 10.1093/nar/gku114. Epub 2014 Feb 5.

20.

Telomere dysfunction and activation of alternative lengthening of telomeres in B-lymphocytes infected by Epstein-Barr virus.

Kamranvar SA, Chen X, Masucci MG.

Oncogene. 2013 Dec 5;32(49):5522-30. doi: 10.1038/onc.2013.189. Epub 2013 May 27.

Supplemental Content

Support Center